(Q34790184)

4 August 2017

title

Timing of initiation of antiretroviral drugs during tuberculosis therapy (English)

1 reference

4 August 2017

main subject

anti-retroviral agent

0 references

0 references

15

Quarraisha Abdool Karim

0 references

Tanuja N. Gengiah

Tanuja Gengiah

7

0 references

Andrew Gray

Andrew Gray

6

0 references

Kogieleum Naidoo

Kogieleum Naidoo

2

0 references

Salim Abdool Karim

Salim S Abdool Karim

1

0 references

Anneke C. Grobler

Anneke Grobler

3

0 references

Nesri Padayatchi

Nesri Padayatchi

4

0 references

Cheryl Baxter

5

Cheryl Baxter

1 reference

4 August 2017

13

Wafaa El-Sadr

1 reference

4 August 2017

8

Gonasagrie Nair

1 reference

4 August 2017

9

Sheila Bamber

1 reference

4 August 2017

14

Gerald Friedland

1 reference

4 August 2017

Aarthi Singh

10

1 reference

4 August 2017

Munira Khan

11

1 reference

4 August 2017

Jacqueline Pienaar

12

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

The New England Journal of Medicine

4 August 2017

published in

1 reference

4 August 2017

volume

362

1 reference

4 August 2017

issue

8

1 reference

4 August 2017

page(s)

697-706

1 reference

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076221

Effect of early versus deferred antiretroviral therapy for HIV on survival

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076221

Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076221

Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076221

Interactions among drugs for HIV and opportunistic infections

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076221

Pulmonary tuberculosis in AIDS patients: transient chest radiographic worsening after initiation of antiretroviral therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076221

Issues in the treatment of active tuberculosis in human immunodeficiency virus-infected patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076221

Paradoxical reactions in HIV and pulmonary TB.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076221

Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076221

Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076221

Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076221

Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076221

Durban 2000 to Toronto 2006: The evolving challenges in implementing AIDS treatment in Africa

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076221

Influence of highly active anti-retroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patients

9 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076221

Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa

9 December 2018

1 reference

12 December 2020

Changing Clinical Presentation and Survival in HIV-Associated Tuberculosis After Highly Active Antiretroviral Therapy

1 reference

12 December 2020

Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy

1 reference

12 December 2020

Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy

1 reference

12 December 2020

Antiretroviral therapy for HIV-infected tuberculosis patients saves lives but needs to be used more frequently in Thailand

1 reference

12 December 2020

Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis

1 reference

12 December 2020

Identifiers

DOI

10.1056/NEJMOA0905848

1 reference

4 August 2017

1 reference

4 August 2017

1 reference